- Corporate Officers - G
- Guggenhime Andrew
Insider Trading History of Guggenhime Andrew
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Guggenhime Andrew since 2016.
This trader's CIK number is 1230724.
At the time of last reporting, Guggenhime Andrew was the PRESIDENT AND CFO of Vaxcyte, Inc.. (stock ticker symbol PCVX).
Also see all insider trading activities at Vaxcyte, Inc..
Note that in the past
GUGGENHIME ANDREW also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Vaxcyte, Inc. (PCVX) by Guggenhime Andrew
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | PCVX | 0 | $0 | 16,000 | $1,368,960 | 20,777 | $185,582 |
2024 | PCVX | 0 | $0 | 130,000 | $11,795,054 | 149,108 | $1,095,429 |
2023 | PCVX | 0 | $0 | 30,000 | $1,624,192 | 30,000 | $160,500 |
2022 | PCVX | 0 | $0 | 60,800 | $1,621,637 | 60,800 | $325,279 |
2021 | PCVX | 0 | $0 | 6,200 | $151,435 | 6,200 | $33,170 |
Yearly summary of insider trading at Dermira, Inc. (DERM) by Guggenhime Andrew
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | DERM | 0 | $0 | 0 | $0 | 34,975 | $0 |
2018 | DERM | 0 | $0 | 0 | $0 | 8,075 | $0 |
2017 | DERM | 0 | $0 | 0 | $0 | 4,750 | $0 |
2016 | DERM | 0 | $0 | 60,000 | $1,982,450 | 61,188 | $330,600 |
Insider trading activities at 2 companies by Guggenhime Andrew:
1. Vaxcyte, Inc. (PCVX)
2. Dermira, Inc. (DERM)
Table 1. Insider trading of Vaxcyte, Inc. (PCVX) by Guggenhime Andrew
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-04-07 | PCVX | Option Ex | 4,777 | 20.93 | 99,982 |
2025-02-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2025-02-18 | PCVX | Sale | 8,000 | 84.11 | 672,880 |
2025-01-21 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2025-01-21 | PCVX | Sale | 8,000 | 87.01 | 696,080 |
2024-12-18 | PCVX | Sale | 8,000 | 88.88 | 711,024 |
2024-12-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-11-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-11-18 | PCVX | Sale | 8,000 | 86.38 | 691,016 |
2024-10-25 | PCVX | Option Ex | 19,108 | 20.93 | 399,930 |
2024-10-18 | PCVX | Option Ex | 42,000 | 5.35 | 224,699 |
2024-10-18 | PCVX | Sale | 42,000 | 115.73 | 4,860,534 |
2024-09-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-09-18 | PCVX | Sale | 8,000 | 116.47 | 931,784 |
2024-08-19 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-08-19 | PCVX | Sale | 8,000 | 78.69 | 629,536 |
2024-07-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-07-18 | PCVX | Sale | 8,000 | 81.66 | 653,248 |
2024-06-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-06-18 | PCVX | Sale | 8,000 | 72.22 | 577,800 |
2024-05-20 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-05-20 | PCVX | Sale | 8,000 | 74.93 | 599,424 |
2024-04-18 | PCVX | Sale | 8,000 | 61.57 | 492,584 |
2024-04-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-03-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-03-18 | PCVX | Sale | 8,000 | 69.32 | 554,568 |
2024-02-20 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2024-02-20 | PCVX | Sale | 8,000 | 75.02 | 600,144 |
2024-01-18 | PCVX | Sale | 8,000 | 61.67 | 493,392 |
2024-01-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2023-12-14 | PCVX | Sale | 14,000 | 60.22 | 843,080 |
2023-12-14 | PCVX | Option Ex | 14,000 | 5.35 | 74,900 |
2023-11-20 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2023-11-20 | PCVX | Sale | 8,000 | 51.53 | 412,280 |
2023-10-18 | PCVX | Option Ex | 8,000 | 5.35 | 42,800 |
2023-10-18 | PCVX | Sale | 8,000 | 46.10 | 368,832 |
2022-09-19 | PCVX | Sale | 3,100 | 26.27 | 81,437 |
2022-09-19 | PCVX | Option Ex | 3,100 | 5.35 | 16,585 |
2022-08-25 | PCVX | Option Ex | 17,052 | 5.35 | 91,228 |
2022-08-26 | PCVX | Option Ex | 1,295 | 5.35 | 6,928 |
2022-08-25 | PCVX | Sale | 17,052 | 28.00 | 477,456 |
2022-08-26 | PCVX | Sale | 1,295 | 28.00 | 36,260 |
2022-08-29 | PCVX | Option Ex | 17,653 | 5.35 | 94,443 |
2022-08-29 | PCVX | Sale | 17,653 | 28.00 | 494,284 |
2022-07-18 | PCVX | Sale | 3,100 | 24.77 | 76,771 |
2022-07-18 | PCVX | Option Ex | 3,100 | 5.35 | 16,585 |
2022-07-08 | PCVX | Option Ex | 3,100 | 5.35 | 16,585 |
2022-07-08 | PCVX | Sale | 3,100 | 24.00 | 74,400 |
2022-05-18 | PCVX | Sale | 3,100 | 24.74 | 76,694 |
2022-05-18 | PCVX | Option Ex | 3,100 | 5.35 | 16,585 |
2022-04-18 | PCVX | Option Ex | 3,100 | 5.35 | 16,585 |
2022-04-18 | PCVX | Sale | 3,100 | 24.05 | 74,542 |
2022-03-18 | PCVX | Option Ex | 3,100 | 5.35 | 16,585 |
2022-03-18 | PCVX | Sale | 3,100 | 26.13 | 80,993 |
2022-03-01 | PCVX | Sale | 6,200 | 24.00 | 148,800 |
2022-03-01 | PCVX | Option Ex | 6,200 | 5.35 | 33,170 |
2021-12-23 | PCVX | Sale | 3,100 | 24.00 | 74,400 |
2021-12-23 | PCVX | Option Ex | 3,100 | 5.35 | 16,585 |
2021-11-18 | PCVX | Sale | 3,100 | 24.85 | 77,035 |
2021-11-18 | PCVX | Option Ex | 3,100 | 5.35 | 16,585 |
Table 2. Insider trading of Dermira, Inc. (DERM) by Guggenhime Andrew
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-08-15 | DERM | Option Ex | 9,975 | .00 | 0 |
2019-05-17 | DERM | Option Ex | 25,000 | .00 | 0 |
2018-08-15 | DERM | Option Ex | 8,075 | .00 | 0 |
2017-08-15 | DERM | Option Ex | 4,750 | .00 | 0 |
2016-11-09 | DERM | Sale | 4,100 | 35.02 | 143,582 |
2016-11-09 | DERM | Option Ex | 4,100 | 5.51 | 22,591 |
2016-10-11 | DERM | Option Ex | 10,900 | 5.51 | 60,059 |
2016-10-11 | DERM | Sale | 10,900 | 34.66 | 377,848 |
2016-09-19 | DERM | Option Ex | 15,000 | 5.51 | 82,650 |
2016-09-19 | DERM | Sale | 15,000 | 35.01 | 525,150 |
2016-09-12 | DERM | Option Ex | 10,000 | 5.51 | 55,100 |
2016-09-12 | DERM | Sale | 10,000 | 32.53 | 325,300 |
2016-08-15 | DERM | Option Ex | 1,188 | .00 | 0 |
2016-08-11 | DERM | Sale | 10,000 | 31.02 | 310,170 |
2016-08-11 | DERM | Option Ex | 10,000 | 5.51 | 55,100 |
2016-07-11 | DERM | Option Ex | 10,000 | 5.51 | 55,100 |
2016-07-11 | DERM | Sale | 10,000 | 30.04 | 300,400 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Guggenhime Andrew
(PRESIDENT AND CFO of Vaxcyte, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.